FUNDC1 and Alzheimer disease: Postmortem AD brains show reduced FUNDC1 activity alongside hyperphosphorylated Ser13/Tyr18, which correlates with Aβ plaque burden and Tau neurofibrillary tangles (Fang et al., 2019).